Analysis of phyllodes tumor recurrence according to the histologic grade

[1]  L. Chong,et al.  Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: novel markers in biological classification , 2012, BMC Proceedings.

[2]  Sunil R. Lakhani,et al.  WHO classification of tumours of the breast , 2012 .

[3]  W. Jung,et al.  Molecules involved in epithelial–mesenchymal transition and epithelial–stromal interaction in phyllodes tumors: implications for histologic grade and prognosis , 2012, Tumor Biology.

[4]  P. Tan,et al.  Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins , 2011, Journal of Clinical Pathology.

[5]  M. Bollet,et al.  Management of Phyllodes Breast Tumors , 2011, The breast journal.

[6]  R. Scolyer,et al.  p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours , 2010, Histopathology.

[7]  P. Tan,et al.  Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors , 2009, Breast Cancer Research and Treatment.

[8]  D. Giri,et al.  Clinicopathologic Features and Long-Term Outcomes of 293 Phyllodes Tumors of the Breast , 2007, Annals of Surgical Oncology.

[9]  P. Tan,et al.  p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study , 2005, Modern Pathology.

[10]  C. Tzen,et al.  Surgical treatment of phyllodes tumors of the breast: Retrospective review of 172 cases , 2005, Journal of surgical oncology.

[11]  P. Tan,et al.  Phyllodes tumors of the breast: the role of pathologic parameters. , 2005, American journal of clinical pathology.

[12]  P. Tan,et al.  Phyllodes Tumors of the Breast , 2005 .

[13]  P. Tan,et al.  Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death , 2005, Modern Pathology.

[14]  R. Scolyer,et al.  Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases. , 2004, Human pathology.

[15]  R. Barth.  Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors , 1999, Breast Cancer Research and Treatment.

[16]  J. Ryś,et al.  Prognostic Evaluation of Proliferative Activity and DNA Content in the Phyllodes Tumor of the Breast: Immunohistochemical and Flow Cytometric Study of 118 Cases , 2004, Breast Cancer Research and Treatment.

[17]  R. Scolyer,et al.  Tumour Angiogenesis and p53 Protein Expression in Mammary Phyllodes Tumors , 2003, Modern Pathology.

[18]  P. Rosen.  Rosen's Breast Pathology , 2001 .

[19]  E. Berns,et al.  Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast , 1999, The Journal of pathology.

[20]  C. S. Lee,et al.  Malignant phyllodes tumours of the breast display increased stromal p53 protein expression , 1999, Histopathology.

[21]  S. Pinder,et al.  Phyllodes tumours of the breast: a clinicopathological review of thirty‐two cases , 1995, Histopathology.

[22]  C. Bartoli,et al.  Which therapy for unexpected phyllode tumour of the breast? , 1992, European journal of cancer.

[23]  S. Andreola,et al.  Surgical treatment of phyllodes tumors of the breast , 1989, Cancer.

[24]  B. Ng,et al.  Cystosarcoma phyllodes: a review of surgical options. , 1989, Surgery.

[25]  L. Barnes,et al.  Cystosarcoma phyllodes. A clinicopathologic analysis of 42 cases , 1978, Cancer.

[26]  S. Hajdu,et al.  Recurrent cystosarcoma phyllodes. A clinicopathologic study of 32 cases , 1976, Cancer.